Study Duration for Clinical Trials with Survival Response and Early Stopping Rule

DOI10.2307/2531632MaRDI QIDQ3201550zbMATH OpenOpenAlexWikidataFDO

Authors KyungMann Kim, Anastasios A. Tsiatis

Publication date 1990

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2307/2531632

zbMATH Keywords

log-rank testsurvival analysisproportional hazards modelinformation timecomparative clinical trialgroup sequential design and analysisuse function

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)

Recommendations

• Planning the duration of a survival group sequential trial with a fixed follow-up time for all subjects
• Duration of accrual and follow-up for two-stage clinical trials
• A two-sample parametric group sequential procedure for monitoring clinical trials
• Stopping rules for long-term clinical trials based on two consecutive rejections of the null hypothesis
• scientific article; zbMATH DE number 1157175

Cited in

(5)

• Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events
• Planning the duration of a survival group sequential trial with a fixed follow-up time for all subjects
• Survival analysis with time-varying regression effects using a tree-based approach
• Duration of accrual and follow-up for two-stage clinical trials
• Stopping rules for long-term clinical trials based on two consecutive rejections of the null hypothesis

This page was built for publication: Study Duration for Clinical Trials with Survival Response and Early Stopping Rule

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201550)